By Editor , 12 September 2026
Unicycive Faces Securities Class Action Over Manufacturing Disclosure Lapses

New York – September 11, 2026 -- Bronstein, Gewirtz & Grossman, LLC has filed a class action lawsuit against Unicycive Therapeutics, Inc. (NASDAQ: UNCY) and certain of its officers, alleging violations of federal securities laws tied to the company's handling of a third-party manufacturing vendor's compliance issues.